title: A controlled trial of azapropazone in tinnitus.
abstract: A single-blind placebo-controlled trial of azapropazone, a non-steroidal anti-inflammatory drug, is presented in 10 patients with tinnitus. Seventeen variables were assessed by questionnaire and six by a daily diary. In none of these was there a significant difference between placebo and drug. A larger trial is probably therefore not justified.
authors.affiliation: ENT Department, University Hospital of Wales, Cardiff.
authors.forename: P J
authors.initials: PJ
authors.lastname: Stoney
authors.forename: D E
authors.initials: DE
authors.lastname: Callaghan
authors.forename: F S
authors.initials: FS
authors.lastname: Walker
authors.forename: S D
authors.initials: SD
authors.lastname: Stephens
mesh_terms: D001032:Apazone / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008499:Medical Records; D016037:Single-Blind Method; D011795:Surveys and Questionnaires; D014012:Tinnitus / Q000188:drug therapy*
chemical_list: D001032:Apazone